HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB: HSTC) today announced it has entered into a formal agreement which outlines the deal points associated with the acquisition of its first Wellness Center located in Reno, Nevada.
This pending acquisition is a part of the evolution of HST’s development of a global presence in the emerging immunotherapy treatment of cancer.
Ron Howell, President and CEO of HST Global, Inc. stated, “HST is excited to have completed the initial due diligence to move forward with the final documentation necessary for this acquisition. The execution of the Acquisition Agreement for the proven FIT technology is a significant step in our strategic global expansion plans.”
About HST Global, Inc.
HST Global, Inc. is an Integrated Biotechnology Health and Wellness company that is developing and or acquiring a network of Wellness Centers worldwide that are primarily focused on the immunotherapy and alternative treatment of late stage cancer. In addition, the company intends to acquire innovative products for the treatment of late stage cancer. In this regard, the company primarily focuses on immunotherapy and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer.
HST Global, Inc. wishes to inform readers that forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward looking statements involve risks and uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical trials by others; possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.